A growing body of literature is suggesting that there is a link between head and neck cancer treated with radiation therapy and the development of obstructive sleep apnea/ hypopnea syndrome (OSAHS). We describe the case of a 54-year-old man with a history of head and neck cancer whose OSAHS had gone undiagnosed for 3 yea rs. After the diagnosis was made on the basis of sleep study data, we determined that the OSAHS was a long-term comp lication ofcervical radiation therapy that had been delivered to treat the patient 's laryngeal squamous cell carcinoma 3 years earlier: We also review the literature regarding the association between head and neck cancer and the development of OSAHS.
Introduction
Obstru ctive sleep apnea/ hypo pnea syndrome (OSA HS) is characterized by repe titive airway collapse during sleep . Th e site of airway collapse exte nds fro m the velopharynx to the hypoph arynx; in so me patient s, more than one site of obs truc tion is involved. I Weight gain, which narrows the upper air way seco ndary to the deposition of adipose in the paraph aryngeal space, is the most commo n risk fac tor forOSAHS . In nonobese individuals, airway abnor malities and cra niofacial abn orm alities that narrow the airway may predi spose to the deve lopment of respir atory disturbances during sleep."
Because the sequelae of untreated OSA HS are significant, prompt diagnosis and treatm ent are crucial. Unfor tunatel y, most cases of OSAHS are undiagnosed,' and patients with atyp ical symptoms may go unrecognized. Awareness of the risk fac tors for the deve lopment of OSA HS makes it possi ble to determine which patients sho uld be screened for this co ndition. We describe a case of OSAHS that occurred as a result ofcervical radiation therapy for laryngeal From squa mous cell carc inoma. We also review the liter atur e regarding the associ ation betw een head and neck canc er and the developm ent of OSAHS .
Case report
A 54-year-old man with T IN2b MO squa mous cell carci noma of the right phary ngoepiglottic fold (status post rig ht modifie d neck dissection and subse quent radiatio n therapy 3 yea rs earlier) was referred to our sleep center with co mplaints of poor sleep, som nambulance (sleepwa lki ng), and somni loquy (sleep talking). His symptoms had begun shortly after the completion of his radiation therapy. Prior to referr al, he had bee n treated for depressio n and insomnia, but no cha nges in his sleep symptoms had occu rred . A further sleep history obtained from the patient and his wife revealed that the man freq uently awoke dur ing the night chok ing and gas ping. He also snored, and his wife had wit nessed some apneas. His wife report ed that the patient was very active ("co nstantly jerking") dur ing sleep. She sa id he would talk and make purp oseful gestures as if he were tryin g to build so mething.The patient reported slee pwalking, ofte n wakin g to find himself sitting on the floor. He did not feel refreshed after sleep. In fac t, he was very sleepy during the day and had stopped wor king as a result. His Epworth sleepi ness sca le sco re was 23 out of a possibl e 24 (a score > I0 sugges ts pathologic sleepi ness) . A rev iew of symptoms revealed chronic hoarseness and dysph agia with solids. Th e patien t denied morning headaches.
On physical exa mination , the patient's body mass index was 21.3 (within the normal range) . He had a left nasal septal dev iation and scarring of the right side of the neck in the area of his previous surgery and radiation. His oropharynx was graded as Ma llampati class III (only the soft palate and tongue were visible upo n open ing of the oropharynx and exte nsio n of the tongue), and no stridor was heard over his trachea.
A 19-chann el overnight polysom nography that included full seizure-mo ntage electroe ncep halog raphy and video reco rding was performed. Th e polyso mnogram revealed extremely severe obstructive sleep ap nea, and the patient' s apnea/hypopnea index (AHI) was 94 eve nts per hour; he ex perience d 561 apneas over a 6-ho ur period of slee p.
Accompanying this finding was a marked degree of oxygen desaturation into the 60th and 70th percentil e ran ge durin g rapid-eye-m ovement (REM) sleep. No seizure act ivity was noted , alth ough the patient was observe d to have thrashed about durin g his sleep because of his breathin g difficulty.
The patie nt was prescribed non invasive ventilation. However, even with bilevel pressure support settings of 20/16 em Hp with a 3-L/min oxygen bleed, the patient continu ed to ex perience significant respiratory disturban ces with desaturation s. Th erefore, a volume-cycled ventilator was used with a full-face mask interface. On a volumecycled ventilator in an assist-control mode with 2 L/min of oxygen , the patient was able to achie ve satisfactory oxygen saturat ion and ade quate control of his sleep apnea. He was kept on nonin vasive ventilation at home, and his symptoms dimini shed but did not completely resolve.
In view of the severity of the patient 's sleep apnea in the context of his medical history, an upper airw ay fiberoptic exa mination was perform ed by the ENT service. Thi s investigation revealed the presence of significant fibrotic tissue in the suprag lottic larynx with airw ay narrowing, as well as edema of the false vocal folds . No evidence of tumo r recurrence was noted. Computed tom ography (CT) of the neck was ordered to better evaluate the patient's airway . CT demonstrated a marked narro wing of the airway in the area of the laryn x but no definite soft-tissue abnormality (figure) . These findings were interpreted to represent mucosa l edema without evidence of canc er recurrence.
A tracheostomy was recommended, and the patient agreed. Foll owin g tracheostomy with placement of a perm anent tube, his nocturnal oxygen saturation level increased dram aticall y and all of his sleep-related symptoms resolved completely.
Discussion
Friedm an et al described a high rate of OSAHS in a series of 24 patient s treated for head and neck cancer.' AIl 24 patient s had an AHI greater than 5, and 67% of them met the criteria for the consensus definiti on of clini caIly significant OSAHS. 5Thi s rate is sign ificantly higher than the often-cited rate of 2 to 4% in middle-aged adults overall." Moreover, obes ity was absent in this group (mean 8MI: 22) . Numero us hypotheses were offered to explain the high rate of OSA HS in this popul ation, including anatomic airwa y modificati on ca used by surgery or tumor burden, a loss of pharyngeal muscle function foIlowin g surgery, and the effects of radiation therapy. It is interesting that all 10 patient s in this series who had unde rgone radiation therapy had polysomn ograph ic evidence of sleep-disordered breathing, comp ared with only 79 % (I 1/14) of those who were not treated with rad iation . Thi s suggests that radiotherapy may play a significant role in the development of OSAHS in patients with head and neck cancer. 102 Figure. CT ofth e neck demonstrates the marked na rrowing ofthe airway in the area of the laryn x but no definite soft -tissue abno rmality. These findings are consis tent with mu cosal edema.
The patient described herein had undergone a full course of radiation treatment. Based on his physical examination and neck CT findings, we believe that it is highl y likely that radiotherapy was the major factor in the development of his sleep apnea .
Radiotherapy is an import ant part of the treatment of localized and advanc ed head and neck cance r, of course, and the dec ision to use it depend s on the primary site of the tumor and the extent of regional disease, parti cularly nodal involvement. ' In the management of hypopharyngeal can cer, primary radiotherapy is used for patients ( I) who have earl y malign ancies, (2) who have a prim ary malignancy of the posterio r pha ryngeal wall , (3) who refuse or are too sick for surg ical resection, or (4) who need palliative therapy to redu ce the bulk of a tumor," Radiotherapy can be used in comb ination with surgery or chemotherapy. The acute side effec ts of radi ation for head and neck cancer include mucositis, odynophagia, dysph agia, hoarseness, xerostomia, and dermatitis; their seve rity is relat ed to the amount of the dail y dose." Cases of acute OSAHS following radi ation therap y have also been reported . 10 The chronic side effects of radiation treatm ent are related to the total dosage of radiati on. They include xeros tomia, osteoradionecrosis, thyroid dysfunction , fibrosis of the norm al tissues surro unding the cancer, and airway ede ma." Our report adds to the numb er of cases in the literature that have documented the delayed developm ent of OSAHS following radiation treatment of the head and neck.v":!' OSAHS should now be considered a potential compl ication of this specific therapy.
Most The typical sy mptoms ofOSAHS are excessive daytime slee piness , insomnia, loud snoring, morning he adaches, and dry mouth upon awakening. Because some of these symptoms are nonspecific and may be seen in a variety of disea se states, including mali gnancy and depression , it is not uncommon for patient s with sleep apnea to be treated for other diagnoses for years before the co rrect diagnosis is made.P In fact , this situation occurred in the case described herein, as our pat ient had been treat ed for insomnia and depr ession durin g the 3 years preceding his diagnosis of OSAHS . Clinici ans who care for patients who fit into a high-risk profil e for OSAHS should aggressively screen for thi s condition. Patients with head and neck cancer, especi ally those who undergo radiotherapy, should be included in thi s high-risk group. Otolaryngologists also need to reco gni ze that not all patients with OSAHS fit the clas sic profile-that is, an obese, loud snorer who is unable to maintain wakefulnes s. Atypical symptoms, such as abnormal beha vior s during sleep, may be the first clue to the pre sence of OSAHS, and they warrant further ev aluation .
Th e standard treatment for OSAHS-noninvasive ventilation-may not be adequate for patients with radiationinduc ed OSAHS.ln our patient , the airflow obstruction was attributable to a relat ively fixed airway abnormality, and thus nonin vasive ventil ation was only marginally effective. Som e other treatm ent mod alities for OSAHS-among them wei ght loss, dent al appli ances, and mandibular surgery-would not be expected to be effective because they do not address the underlying pathology. Treatments that are not typic ally considered for OSAHS-for example, CO 2 laser vaporization targeting laryngeal edema-may be worth considerin g, depending on the specific patient's airway anatorny.I'Tracheostom y,the only definitive therapy for slee p apnea, can be performed if standard ventilation therapy fail s or if the clinical situation requires it. Because the site of airway obstruction following treatment of head and neck ca ncer is typic ally at the level of the larynx and not at the lev el of the soft palate or the base of the tongue,17 dia gno stic modalities such as CT of the neck should be considered for patients who are found to have OSAHS. This may help to determine the optimal therapeutic approa ch for a given patient. Clinician s who care for patients with a history of head and neck cancer, especially tho se who have received rad iation therap y, need to have a high inde x of suspicion for OSAHS . Pol ysomnography should be ordered for patient s who complain of excessive daytime sleepiness or insomnia.
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